/Companies

Averywell

1 known investors

Find your way into Averywell

Sign up to see every warm intro you have to Averywell

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Averywell team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.

Investors · 1

Funding

SEC filings, press & company announcements
  • Undisclosed amountpre-seed funding roundApr 2024

    Genesis Ventures (lead)

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Averywell do?
Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.
Who are Averywell's investors?
Averywell's investors include Genesis Ventures.